US Patent:
20120220596, Aug 30, 2012
Inventors:
James M. Cook - Milwaukee WI, US
David A. Baker - Grafton WI, US
Wenyuan Yin - Milwaukee WI, US
Assignee:
UWM RESEARCH FOUNDATION, INC. - Milwaukee WI
MARQUETTE UNIVERSITY - Milwaukee WI
International Classification:
A61K 31/495
C07D 211/86
A61K 31/45
C07D 487/04
A61K 31/4985
A61K 31/4965
C07D 403/12
A61K 31/497
C07C 327/34
A61K 31/21
C07C 323/60
A61K 31/24
A61K 31/225
A61P 25/30
A61P 25/18
C07D 241/08
US Classification:
514249, 544385, 51425502, 546243, 514315, 544349, 544408, 5142521, 544357, 51425211, 558254, 514513, 560 16, 514533, 560147, 514547
Abstract:
The present invention provides cysteine and cystine prodrugs for the treatment of schizophrenia and drug addiction. The invention further encompasses pharmaceutical compositions containing prodrugs and methods of using the prodrugs and compositions for treatment of schizophrenia and drug addiction.